Efficacy of aflibercept in resistant neovascular age-related macular degeneration (nAMD) patients who had been treated and failed prior bevacizumab or ranibizumab injections.
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 28 Aug 2017 New trial record